Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Hein

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
International Journal of Epidemiology|May 19, 2007
Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learnedNathaniel Rothman, Montserrat Garcia-Closas, David W Hein
Biological Chemistry|September 12, 2002
Functional genomics of C190T single nucleotide polymorphism in human N-acetyltransferase 2Yuanqi Zhu, Mark A Doll, David W Hein
Pharmacogenomics|November 6, 2007
Clinical pharmacogenetics in pediatric patientsAnwar Husain, Jennifer A Loehle, David W Hein
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2007
Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and functionJason M Walraven, John O Trent, David W Hein
Journal of Surgical Oncology|September 5, 2002
Genetic profiling of colon cancerHolly L Neibergs, David W Hein, John S Spratt
Frontiers in Pharmacology|November 17, 2022
Acetyl coenzyme A kinetic studies on <i>N</i>-acetylation of environmental carcinogens by human <i>N</i>-acetyltransferase 1 and its <i>NAT1*14B</i> variantMariam R Habil, Mark A Doll, David W Hein
Pharmacogenetics and Genomics|January 3, 2020
N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytesMariam R Habil, Mark A Doll, David W Hein
International Journal of Cancer|March 30, 2006
Effects of single nucleotide polymorphisms in human N-acetyltransferase 2 on metabolic activation (O-acetylation) of heterocyclic amine carcinogensDavid W Hein, Adrian J Fretland, Mark A Doll
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 12, 2017
<i>N</i>-Acetyltransferase 2 Genotype-Dependent <i>N</i>-Acetylation of Hydralazine in Human HepatocytesCecily E Allen, Mark A Doll, David W Hein
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 10, 2008
4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator ratsFelicia A Jefferson, Gong H Xiao, David W Hein
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Epidemiology|May 19, 2007
Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learnedNathaniel Rothman, Montserrat Garcia-Closas, David W Hein
Biological Chemistry|September 12, 2002
Functional genomics of C190T single nucleotide polymorphism in human N-acetyltransferase 2Yuanqi Zhu, Mark A Doll, David W Hein
Pharmacogenomics|November 6, 2007
Clinical pharmacogenetics in pediatric patientsAnwar Husain, Jennifer A Loehle, David W Hein
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2007
Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and functionJason M Walraven, John O Trent, David W Hein
Journal of Surgical Oncology|September 5, 2002
Genetic profiling of colon cancerHolly L Neibergs, David W Hein, John S Spratt
Frontiers in Pharmacology|November 17, 2022
Acetyl coenzyme A kinetic studies on <i>N</i>-acetylation of environmental carcinogens by human <i>N</i>-acetyltransferase 1 and its <i>NAT1*14B</i> variantMariam R Habil, Mark A Doll, David W Hein
Pharmacogenetics and Genomics|January 3, 2020
N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytesMariam R Habil, Mark A Doll, David W Hein
International Journal of Cancer|March 30, 2006
Effects of single nucleotide polymorphisms in human N-acetyltransferase 2 on metabolic activation (O-acetylation) of heterocyclic amine carcinogensDavid W Hein, Adrian J Fretland, Mark A Doll
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 12, 2017
<i>N</i>-Acetyltransferase 2 Genotype-Dependent <i>N</i>-Acetylation of Hydralazine in Human HepatocytesCecily E Allen, Mark A Doll, David W Hein
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 10, 2008
4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator ratsFelicia A Jefferson, Gong H Xiao, David W Hein
Pageof 18